Skip to main content
SpringerLink
Log in
Book cover

Tumors of the Central Nervous System, Volume 14 pp 67–77Cite as

Evidence-Based Approach for the Management of Cerebral Metastases from Lung Adenocarcinoma

  • Chapter

  • 877 Accesses

Part of the book series: Tumors of the Central Nervous System ((TCNS,volume 14))

Abstract

Adenocarcinoma is the most common histologic subtype of lung cancer in most countries, accounting for almost half of all lung cancers. A considerable proportion of non-small-cell lung cancer [NSCLC] patients will develop central nervous system [CNS] metastases throughout the course of their disease and these manifestations cause significant morbidity and mortality. Thus, aggressive management of cerebral metastases is vital to preventing death from neurological causes and prolonging functional independence. This chapter focuses on current knowledge of pathology, imaging and management of brain metastases from lung adenocarcinoma and outlines a practical approach for the management of cerebral metastases.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Abrey LE, Olson JD, Raizer JJ, Mack M, Rodavitch A, Boutros DY, Malkin MG (2001) A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J Neurooncol 53(3):259–265

    Article  CAS  PubMed  Google Scholar 

  • Akeson P, Nordstrom CH, Holtas S (1997) Time-dependency in brain lesion enhancement with gadodiamide injection. Acta Radiol 38(1):19–24

    Article  CAS  PubMed  Google Scholar 

  • Al-Okaili RN, Krejza J, Wang S, Woo JH, Melhem ER (2006) Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults. Radiographics 26(Suppl 1):S173–S189

    Article  PubMed  Google Scholar 

  • Bailon O, Chouahnia K, Augier A, Bouillet T, Billot S, Coman I, Ursu R, Belin C, Zelek L, Des Guetz G, Levy C, Carpentier AF, Morere JF (2012) Upfront association of carboplatin plus pemetrexed in patients with brain metastases of lung adenocarcinoma. Neuro Oncol 14(4):491–495

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Baleriaux D, Colosimo C, Ruscalleda J, Korves M, Schneider G, Bohndorf K, Bongartz G, van Buchem MA, Reiser M, Sartor K, Bourne MW, Parizel PM, Cherryman GR, Salerio I, La Noce A, Pirovano G, Kirchin MA, Spinazzi A (2002) Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine. Neuroradiology 44(3):191–203

    Article  CAS  PubMed  Google Scholar 

  • Ba-Ssalamah A, Nobauer-Huhmann IM, Pinker K, Schibany N, Prokesch R, Mehrain S, Mlynarik V, Fog A, Heimberger K, Trattnig S (2003) Effect of contrast dose and field strength in the magnetic resonance detection of brain metastases. Invest Radiol 38(7):415–422

    PubMed  Google Scholar 

  • Bearz A, Garassino I, Tiseo M, Caffo O, Soto-Parra H, Boccalon M, Talamini R, Santoro A, Bartolotti M, Murgia V, Berretta M, Tirelli U (2010) Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer. Lung Cancer 68(2):264–268

    Article  PubMed  Google Scholar 

  • Bindal RK, Sawaya R, Leavens ME, Lee JJ (1993) Surgical treatment of multiple brain metastases. J Neurosurg 79(2):210–216

    Article  CAS  PubMed  Google Scholar 

  • Brooks DJ (2005) Positron emission tomography and single-photon emission computed tomography in central nervous system drug development. NeuroRx 2(2):226–236

    Article  PubMed Central  PubMed  Google Scholar 

  • Bukte Y, Paksoy Y, Genc E, Uca AU (2005) Role of diffusion-weighted MR in differential diagnosis of intracranial cystic lesions. Clin Radiol 60(3):375–383

    Article  CAS  PubMed  Google Scholar 

  • Carrier DA, Mawad ME, Kirkpatrick JB, Schmid MF (1994) Metastatic adenocarcinoma to the brain: MR with pathologic correlation. AJNR Am J Neuroradiol 15(1):155–159

    CAS  PubMed  Google Scholar 

  • Chua D, Krzakowski M, Chouaid C, Pallotta MG, Martinez JI, Gottfried M, Curran W, Throuvalas N (2010) Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non- small-cell lung cancer: a randomized, open-label phase II study. Clin Lung Cancer 11(3):176–181

    Article  CAS  PubMed  Google Scholar 

  • Colosimo C, Ruscalleda J, Korves M, La Ferla R, Wool C, Pianezzola P, Kirchin MA (2001) Detection of intracranial metastases: a multicenter, intrapatient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dosage. Invest Radiol 36(2):72–81

    Article  CAS  PubMed  Google Scholar 

  • Dziadziuszko R, Ardizzoni A, Postmus PE, Smit EF, Price A, Debruyne C, Legrand C, Giaccone G, Group ELC (2003) Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965). Eur J Cancer 39(9):1271–1276

    Article  CAS  PubMed  Google Scholar 

  • Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37(4):745–751

    Article  CAS  PubMed  Google Scholar 

  • Gore EM, Bae K, Wong SJ, Sun A, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H (2011) Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. J Clin Oncol 29(3):272–278

    Article  PubMed Central  PubMed  Google Scholar 

  • Guo S, Reddy CA, Chao ST, Suh JH, Barnett GH, Vogelbaum MA, Videtic GM (2012) Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases. Lung Cancer 77(2):389–393

    Article  PubMed  Google Scholar 

  • Hakyemez B, Erdogan C, Bolca N, Yildirim N, Gokalp G, Parlak M (2006) Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging 24(4):817–824

    Article  PubMed  Google Scholar 

  • Hatiboglu MA, Wildrick DM, Sawaya R (2013) The role of surgical resection in patients with brain metastases. Ecancermedicalscience 7:308

    PubMed Central  PubMed  Google Scholar 

  • Hayashida Y, Hirai T, Morishita S, Kitajima M, Murakami R, Korogi Y, Makino K, Nakamura H, Ikushima I, Yamura M, Kochi M, Kuratsu JI, Yamashita Y (2006) Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. AJNR Am J Neuroradiol 27(7):1419–1425

    CAS  PubMed  Google Scholar 

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90

    Article  PubMed  Google Scholar 

  • Knauth M, Forsting M, Hartmann M, Heiland S, Balzer T, Sartor K (1996) MR enhancement of brain lesions: increased contrast dose compared with magnetization transfer. AJNR Am J Neuroradiol 17(10):1853–1859

    CAS  PubMed  Google Scholar 

  • Kojima Y, Kuwana N, Noji M, Tosa J (1994) Differentiation of malignant glioma and metastatic brain tumor by thallium-201 single photon emission computed tomography. Neurol Med Chir (Tokyo) 34(9):588–592

    Article  CAS  Google Scholar 

  • Kruger S, Mottaghy FM, Buck AK, Maschke S, Kley H, Frechen D, Wibmer T, Reske SN, Pauls S (2011) Brain metastasis in lung cancer. Comparison of cerebral MRI and 18F-FDG-PET/CT for diagnosis in the initial staging. Nuklearmedizin 50(3):101–106

    Article  CAS  PubMed  Google Scholar 

  • Lee DH, Han JY, Kim HT, Yoon SJ, Pyo HR, Cho KH, Shin SH, Yoo H, Lee SH, Lee JS (2008) Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first: result of a randomized pilot study. Cancer 113(1):143–149

    Article  PubMed  Google Scholar 

  • Nathoo N, Chahlavi A, Barnett GH, Toms SA (2005) Pathobiology of brain metastases. J Clin Pathol 58(3):237–242

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Nussbaum ES, Djalilian HR, Cho KH, Hall WA (1996) Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 78(8):1781–1788

    Article  CAS  PubMed  Google Scholar 

  • Orringer DA, Golby A, Jolesz F (2012) Neuronavigation in the surgical management of brain tumors: current and future trends. Expert Rev Med Devices 9(5):491–500

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Park SJ, Kim HT, Lee DH, Kim KP, Kim SW, Suh C, Lee JS (2012) Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation. Lung Cancer 77(3):556–560

    Article  CAS  PubMed  Google Scholar 

  • Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322(8):494–500

    Article  CAS  PubMed  Google Scholar 

  • Peters S, Adjei AA, Gridelli C, Reck M, Kerr K, Felip E, E. G. W. Group (2012) Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii56–vii64

    Article  PubMed  Google Scholar 

  • Pollock BE, Brown PD, Foote RL, Stafford SL, Schomberg PJ (2003) Properly selected patients with multiple brain metastases may benefit from aggressive treatment of their intracranial disease. J Neurooncol 61(1):73–80

    Article  PubMed  Google Scholar 

  • Posner JB, Chernik NL (1978) Intracranial metastases from systemic cancer. Adv Neurol 19:579–592

    CAS  PubMed  Google Scholar 

  • Preusser M, Capper D, Ilhan-Mutlu A, Berghoff AS, Birner P, Bartsch R, Marosi C, Zielinski C, Mehta MP, Winkler F, Wick W, von Deimling A (2012) Brain metastases: pathobiology and emerging targeted therapies. Acta Neuropathol 123(2):205–222

    Article  CAS  PubMed  Google Scholar 

  • Robinet G, Thomas P, Breton JL, Lena H, Gouva S, Dabouis G, Bennouna J, Souquet PJ, Balmes P, Thiberville L, Fournel P, Quoix E, Riou R, Rebattu P, Perol M, Paillotin D, Mornex F (2001) Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non- small-cell lung cancer: Groupe Francais de Pneumo-Cancerologie (GFPC) Protocol 95–1. Ann Oncol 12(1):59–67

    Article  CAS  PubMed  Google Scholar 

  • Rosell R, Carcereny E, Gervais R, Vergnenegre A, Massuti B, Felip E, Palmero R, Garcia-Gomez R, Pallares C, Sanchez JM, Porta R, Cobo M, Garrido P, Longo F, Moran T, Insa A, De Marinis F, Corre R, Bover I, Illiano A, Dansin E, de Castro J, Milella M, Reguart N, Altavilla G, Jimenez U, Provencio M, Moreno MA, Terrasa J, Munoz-Langa J, Valdivia J, Isla D, Domine M, Molinier O, Mazieres J, Baize N, Garcia- Campelo R, Robinet G, Rodriguez-Abreu D, Lopez-Vivanco G, Gebbia V, Ferrera-Delgado L, Bombaron P, Bernabe R, Bearz A, Artal A, Cortesi E, Rolfo C, Sanchez-Ronco M, Drozdowskyj A, Queralt C, de Aguirre I, Ramirez JL, Sanchez JJ, Molina MA, Taron M, Paz-Ares L, P.-C Spanish Lung Cancer Group in collaboration with Groupe Francais de and T. Associazione Italiana Oncologia (2012) Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol 13(3):239–246

    Article  CAS  PubMed  Google Scholar 

  • Samanci Y, Iplikcioglu C, Ozek E, Ozcan D, Marangozoglu B (2011) Lung carcinoma metastasis presenting as a pineal region tumor. Neurocirugia (Astur) 22(6):579–582

    Article  CAS  Google Scholar 

  • Sanai N, Eschbacher J, Hattendorf G, Coons SW, Preul MC, Smith KA, Nakaji P, Spetzler RF (2011) Intraoperative confocal microscopy for brain tumors: a feasibility analysis in humans. Neurosurgery 68(2 Suppl Operative):282–290; discussion 290

    PubMed  Google Scholar 

  • Shaw AT, Kim DW, Nakagawa K, Seto T, Crino L, Ahn MJ, De Pas T, Besse B, Solomon BJ, Blackhall F, Wu YL, Thomas M, O’Byrne KJ, Moro-Sibilot D, Camidge DR, Mok T, Hirsh V, Riely GJ, Iyer S, Tassell V, Polli A, Wilner KD, Janne PA (2013) Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 368(25):2385–2394

    Article  CAS  PubMed  Google Scholar 

  • Sidhu K, Cooper P, Ramani R, Schwartz M, Franssen E, Davey P (2004) Delineation of brain metastases on CT images for planning radiosurgery: concerns regarding accuracy. Br J Radiol 77(913):39–42

    Article  CAS  PubMed  Google Scholar 

  • Sills AK (2005) Current treatment approaches to surgery for brain metastases. Neurosurgery 57(5 Suppl):S24–S32; discussion S21–24

    PubMed  Google Scholar 

  • Soffietti R, Cornu P, Delattre JY, Grant R, Graus F, Grisold W, Heimans J, Hildebrand J, Hoskin P, Kalljo M, Krauseneck P, Marosi C, Siegal T, Vecht C (2006) EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol 13(7):674–681

    Article  CAS  PubMed  Google Scholar 

  • Soria JC, Mauguen A, Reck M, Sandler AB, Saijo N, Johnson DH, Burcoveanu D, Fukuoka M, Besse B, Pignon JP, N. c. g. meta-analysis of bevacizumab in advanced (2013) Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer. Ann Oncol 24(1):20–30

    Article  PubMed  Google Scholar 

  • Tangjitgamol S, Levenback CF, Beller U, Kavanagh JJ (2004) Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review. Int J Gynecol Cancer 14(3):399–422

    Article  CAS  PubMed  Google Scholar 

  • Tsao M, Xu W, Sahgal A (2012) A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer 118(9):2486–2493

    Article  PubMed  Google Scholar 

  • Vecht CJ, Haaxma-Reiche H, Noordijk EM, Padberg GW, Voormolen JH, Hoekstra FH, Tans JT, Lambooij N, Metsaars JA, Wattendorff AR et al (1993) Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 33(6):583–590

    Article  CAS  PubMed  Google Scholar 

  • Vogelbaum MA, Suh JH (2006) Resectable brain metastases. J Clin Oncol 24(8):1289–1294

    Article  PubMed  Google Scholar 

  • Welsh JW, Komaki R, Amini A, Munsell MF, Unger W, Allen PK, Chang JY, Wefel JS, McGovern SL, Garland LL, Chen SS, Holt J, Liao Z, Brown P, Sulman E, Heymach JV, Kim ES, Stea B (2013) Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer. J Clin Oncol 31(7):895–902

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Welzel G, Fleckenstein K, Schaefer J, Hermann B, Kraus-Tiefenbacher U, Mai SK, Wenz F (2008) Memory function before and after whole brain radiotherapy in patients with and without brain metastases. Int J Radiat Oncol Biol Phys 72(5):1311–1318

    Article  PubMed  Google Scholar 

  • Yokoi K, Kamiya N, Matsuguma H, Machida S, Hirose T, Mori K, Tominaga K (1999) Detection of brain metastasis in potentially operable non- small cell lung cancer: a comparison of CT and MRI. Chest 115(3):714–719

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurosurgery Clinic, Ministry of Health Istanbul Education and Research Hospital, Istanbul, Turkey

    Mustafa Yavuz Samanci

Authors
  1. Mustafa Yavuz Samanci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mustafa Yavuz Samanci .

Editor information

Editors and Affiliations

  1. Kean University, Library building, Department of Biological Sciences, UNION, New Jersey, USA

    M.A. Hayat

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Samanci, M.Y. (2015). Evidence-Based Approach for the Management of Cerebral Metastases from Lung Adenocarcinoma. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 14. Tumors of the Central Nervous System, vol 14. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7224-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-7224-2_7

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-7223-5

  • Online ISBN: 978-94-017-7224-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation